These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26580235)

  • 1. Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity.
    Goldstone AP; Miras AD; Scholtz S; Jackson S; Neff KJ; Pénicaud L; Geoghegan J; Chhina N; Durighel G; Bell JD; Meillon S; le Roux CW
    J Clin Endocrinol Metab; 2016 Feb; 101(2):599-609. PubMed ID: 26580235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.
    Scholtz S; Miras AD; Chhina N; Prechtl CG; Sleeth ML; Daud NM; Ismail NA; Durighel G; Ahmed AR; Olbers T; Vincent RP; Alaghband-Zadeh J; Ghatei MA; Waldman AD; Frost GS; Bell JD; le Roux CW; Goldstone AP
    Gut; 2014 Jun; 63(6):891-902. PubMed ID: 23964100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of satiety gut hormones increases appetitive behavior after curative esophagectomy for esophageal cancer.
    Elliott JA; Docherty NG; Haag J; Eckhardt HG; Ravi N; Reynolds JV; le Roux CW
    Am J Clin Nutr; 2019 Feb; 109(2):335-344. PubMed ID: 30722001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
    Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
    Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.
    Borg CM; le Roux CW; Ghatei MA; Bloom SR; Patel AG; Aylwin SJ
    Br J Surg; 2006 Feb; 93(2):210-5. PubMed ID: 16392104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity surgery and neural correlates of human eating behaviour: A systematic review of functional MRI studies.
    Alabdulkader S; Al-Alsheikh AS; Miras AD; Goldstone AP
    Neuroimage Clin; 2024; 41():103563. PubMed ID: 38237270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Regional Brain Responses to Food Ingestion After Roux-en-Y Gastric Bypass and the Role of Gut Peptides: A Neuroimaging Study.
    Hunt KF; Dunn JT; le Roux CW; Reed LJ; Marsden PK; Patel AG; Amiel SA
    Diabetes Care; 2016 Oct; 39(10):1787-95. PubMed ID: 27660120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
    Murphy CF; Stratford N; Docherty NG; Moran B; Elliott JA; Healy ML; McMorrow JP; Ravi N; Goldstone AP; Reynolds JV; le Roux CW
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e204-e216. PubMed ID: 33000149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes.
    Halliday TM; Polsky S; Schoen JA; Legget KT; Tregellas JR; Williamson KM; Cornier MA
    Physiol Rep; 2019 Apr; 7(7):e14048. PubMed ID: 30927343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satiety and gastrointestinal hormones during a Mixed Meal Tolerance Test after gastric bypass surgery: association with plasma amino acid concentrations.
    van den Broek M; de Heide LJM; Emous M; Wijma RB; Veeger NJGM; Wolthuis A; Laskewitz AJ; Heiner-Fokkema MR; Muller Kobold AC; Wolffenbuttel BHR; van Beek AP
    Surg Obes Relat Dis; 2018 Aug; 14(8):1106-1117. PubMed ID: 29937240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuro-Endo-Microbio-Ome Study: A Pilot Study of Neurobiological Alterations Pre- Versus Post-Bariatric Surgery.
    Agarwal K; Maki KA; Vizioli C; Carnell S; Goodman E; Hurley M; Harris C; Colwell R; Steele K; Joseph PV
    Biol Res Nurs; 2022 Jul; 24(3):362-378. PubMed ID: 35426747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neural responsivity to food cues in relation to food preferences, but not appetite-related hormone concentrations after RYGB-surgery.
    Zoon HFA; de Bruijn SEM; Smeets PAM; de Graaf C; Janssen IMC; Schijns W; Aarts EO; Jager G; Boesveldt S
    Behav Brain Res; 2018 Nov; 353():194-202. PubMed ID: 30041007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled study.
    Behary P; Alessimii H; Miras AD; Tharakan G; Alexiadou K; Aldhwayan MM; Purkayastha S; Moorthy K; Ahmed AR; Bloom SR; Tan TM
    Diabetes Obes Metab; 2023 Jun; 25(6):1731-1739. PubMed ID: 36811311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass.
    de Hollanda A; Casals G; Delgado S; Jiménez A; Viaplana J; Lacy AM; Vidal J
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4677-84. PubMed ID: 26505823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
    Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
    Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.
    Valderas JP; Irribarra V; Boza C; de la Cruz R; Liberona Y; Acosta AM; Yolito M; Maiz A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1069-75. PubMed ID: 20097707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered neural inhibition responses to food cues after Roux-en-Y Gastric Bypass.
    Zoon HFA; de Bruijn SEM; Jager G; Smeets PAM; de Graaf C; Janssen IMC; Schijns W; Deden L; Boesveldt S
    Biol Psychol; 2018 Sep; 137():34-41. PubMed ID: 29944963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.